Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

Featured Releases

December 07, 2025 08:07 ET | Source: HelloNation Staff Writer

Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation

Real Estate Expert Kerry Ramage explains the most reliable way for a homeowner to successfully navigate the fast-changing Brevard County market.
Read More
December 07, 2025 08:00 ET | Source: Mutuum Finance

Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review

DUBAI, United Arab Emirates, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), an emerging decentralized lending protocol, is approaching a major milestone as its presale moves toward a full...
Read More

December 07, 2025 16:58 ET | Source: Former CIA Officer Buck Sexton

Former National Security Analyst Signals a Warning in Recent Presentation: “Most Americans are completely uninformed about China’s ambition and power.”

Washington, D.C., Dec. 07, 2025 (GLOBE NEWSWIRE) -- A former CIA counter-terrorism officer’s recent presentation is urging Americans to understand the full scale of China’s military and...
December 07, 2025 16:30 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell lymphoma in the 3L+ setting83% overall response and 61% complete...
December 07, 2025 16:30 ET | Source: Regeneron Pharmaceuticals, Inc.

Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment

All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better) of ≥70% despite limited follow-up; evidence shows that these...
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
December 07, 2025 15:56 ET | Source: Rally House

Rally House Breaks Company Online Sales Record After Electric Sports Weekend

Rally House sets new company online single-day sales record following an electric sports weekend and holiday shopping.
December 07, 2025 13:00 ET | Source: Coalition of Asia Pacific Tobacco Harm Reduction Advocates

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

This white paper exposes how the World Health Organization's FCTC has been captured by NGOs undermining the treaty's credibility.
December 07, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
December 07, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
December 07, 2025 11:00 ET | Source: Dyne Therapeutics, Inc.

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET

WALTHAM, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...
December 07, 2025 10:11 ET | Source: Kessler Topaz Meltzer & Check LLP

Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Dec. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...

1 2 ...314384